Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Welander distal myopathy

Why Do I Need a Muscle MRI for Welander Distal Myopathy?

At a Glance

While a genetic test confirms a Welander distal myopathy diagnosis, a muscle MRI is necessary to see exactly how the disease physically affects your body. The scan detects early fatty replacement in muscles and establishes a crucial baseline to track your condition's progression over time.

It is very common to wonder why you need an expensive and sometimes uncomfortable imaging test—like having to lie perfectly still inside an enclosed, noisy machine—when a simple genetic blood test has already confirmed you have Welander distal myopathy (WDM). While the genetic test identifies the specific DNA mutation causing your condition, it does not tell your care team how much that mutation is currently affecting your muscles. A muscle MRI is used to confirm the specific pattern of muscle damage, establish a baseline to track how your disease progresses over years or decades, and objectively measure the exact severity of muscle changes happening beneath the skin.

Seeing the Full Picture: Genes vs. Muscle Health

A genetic test confirms the “blueprint” of the disease, showing that you have a mutation (usually in the TIA1 gene) associated with Welander distal myopathy [1][2][3]. However, people with the exact same genetic mutation can experience very different levels of muscle weakness and disease progression.

An MRI (Magnetic Resonance Imaging) provides a detailed, inside look at the actual health of your muscles [4][5]. This allows your doctor to see how the genetic blueprint is actively behaving in your body [6][7]. Because an MRI is primarily looking at the structure of the muscle, this type of scan often does not require an IV or a contrast dye injection, which can make the test a bit easier to manage.

What Does the MRI Look For?

In Welander distal myopathy, the muscle tissue slowly breaks down over a period of many years and is replaced by fat, a process known as fatty replacement or fatty infiltration [8][1][9].

The MRI is highly sensitive to these changes and allows doctors to visualize specific patterns of muscle involvement:

  • Identifying Specific Muscle Patterns: WDM typically affects the muscles furthest from the center of your body. The MRI can confirm fatty replacement in specific lower leg muscles, particularly the gastrocnemius and soleus (the main calf muscles), as well as the tibialis anterior (the muscle along the front of your shin) [10][11][9]. Crucially, the MRI is also used to evaluate the muscles in your hands and forearms, where weakness often begins in this specific condition [8][12].
  • Catching Early Changes: An MRI can detect muscle damage and early fatty replacement before you even notice significant changes in your grip strength or walking ability [13][14][15].

Establishing a Baseline and Tracking Progression

Perhaps the most important role of a muscle MRI after a genetic diagnosis is establishing a baseline [6][7][16].

  • Measuring Severity: The degree of fatty replacement seen on an MRI strongly correlates with the severity of the disease and your daily physical function [1][17][9]. This detailed assessment helps your doctor and physical therapist tailor a specific plan to support the muscles that are most at risk.
  • Monitoring Change Over Time: By having a baseline scan, future MRIs can be compared to see exactly how quickly or slowly the fatty infiltration is progressing [9][1]. This provides objective data that is much more precise than simple physical strength tests [18][19].

Common questions in this guide

Why do I need an MRI if a genetic test already confirmed I have Welander distal myopathy?
A genetic test identifies the specific DNA mutation causing your condition, acting as a blueprint. However, it doesn't show how your muscles are currently affected. An MRI provides a detailed look at the actual physical health of your muscles to establish a baseline and measure disease severity.
What exactly does a muscle MRI look for in this condition?
The MRI looks for patterns of muscle tissue slowly breaking down and being replaced by fat, a process known as fatty replacement. It specifically checks the muscles furthest from the center of your body, including your lower legs, hands, and forearms.
Can an MRI detect Welander distal myopathy changes before I feel weakness?
Yes, a muscle MRI is highly sensitive and can detect early muscle damage and fatty replacement before you notice significant changes in your daily physical abilities. This allows your care team to catch changes before you experience major issues with your grip strength or walking.
Do I need a contrast dye injection for a muscle MRI?
Because a muscle MRI primarily looks at the physical structure of the muscle, it often does not require an IV or contrast dye injection. However, you should always confirm the exact details of your scan with your doctor or the imaging center beforehand.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Will this MRI scan evaluate both my upper extremities (hands/arms) and my lower extremities (legs)?
  2. 2.What specific muscle groups show the most fatty replacement on this MRI?
  3. 3.How does my current MRI compare to what is typically expected for someone at my stage of Welander distal myopathy?
  4. 4.How often should we repeat the muscle MRI to monitor the progression of the disease?
  5. 5.Are there any physical therapy interventions we should prioritize based on the vulnerable areas identified in the MRI?
  6. 6.Does this MRI require a contrast dye injection, or will it be a non-contrast scan?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    A Heterologous Cell Model for Studying the Role of T-Cell Intracellular Antigen 1 in Welander Distal Myopathy.

    Carrascoso I, Sánchez-Jiménez C, Silion E, et al.

    Molecular and cellular biology 2019; (39(1)) doi:10.1128/MCB.00299-18.

    PMID: 30348840
  2. 2

    Dynamics of T-Cell Intracellular Antigen 1-Dependent Stress Granules in Proteostasis and Welander Distal Myopathy under Oxidative Stress.

    Fernández-Gómez A, Velasco BR, Izquierdo JM

    Cells 2022; (11(5)) doi:10.3390/cells11050884.

    PMID: 35269506
  3. 3

    Welander Distal Myopathy-Associated TIA1 E384K Mutation Disrupts Stress Granule Dynamics Under Distinct Stress Conditions.

    Ramos-Velasco B, Alcalde J, Izquierdo JM

    Biology 2025; (14(9)) doi:10.3390/biology14091288.

    PMID: 41007432
  4. 4

    Myopathology in times of modern imaging.

    Jungbluth H

    Neuropathology and applied neurobiology 2017; (43(1)):24-43 doi:10.1111/nan.12385.

    PMID: 28111795
  5. 5

    Muscle Magnetic Resonance Imaging in Patients with Various Clinical Subtypes of LMNA-Related Muscular Dystrophy.

    Lin HT, Liu X, Zhang W, et al.

    Chinese medical journal 2018; (131(12)):1472-1479 doi:10.4103/0366-6999.233957.

    PMID: 29893365
  6. 6

    The value of qualitative muscle MRI in the diagnostic procedures of myopathies: a biopsy-controlled study in 191 patients.

    Lehmann Urban D, Mohamed M, Ludolph AC, et al.

    Therapeutic advances in neurological disorders 2021; (14()):1756286420985256 doi:10.1177/1756286420985256.

    PMID: 33737953
  7. 7

    Imaging alterations in skeletal muscle channelopathies: a study in 15 patients.

    Maggi L, Brugnoni R, Canioni E, et al.

    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2015; (34(2-3)):109-15.

    PMID: 27199537
  8. 8

    Whole Exome Sequencing Identifies Atypical Welander Distal Myopathy in Patient.

    Gass J, Blackburn P, Jackson J, et al.

    Journal of clinical neuromuscular disease 2017; (18(3)):152-156 doi:10.1097/CND.0000000000000164.

    PMID: 28221306
  9. 9

    Distal myopathy due to digenic inheritance of TIA1 and SQSTM1 variants in two unrelated Spanish patients.

    Bermejo-Guerrero L, de Fuenmayor Fernández-de la Hoz CP, González-Quereda L, et al.

    Neuromuscular disorders : NMD 2023; (33(12)):983-987 doi:10.1016/j.nmd.2023.10.016.

    PMID: 38016875
  10. 10

    Autosomal dominant distal myopathy due to p.Ser85Cys mutation in the MATR3 gene: Novel case series and literature review.

    Chitimus DM, Venturelli N, Lefeuvre C, et al.

    Revue neurologique 2025; (181(7)):608-614 doi:10.1016/j.neurol.2025.04.011.

    PMID: 40447473
  11. 11

    Clinicopathologic Features of Oculopharyngodistal Myopathy With LRP12 CGG Repeat Expansions Compared With Other Oculopharyngodistal Myopathy Subtypes.

    Kumutpongpanich T, Ogasawara M, Ozaki A, et al.

    JAMA neurology 2021; (78(7)):853-863 doi:10.1001/jamaneurol.2021.1509.

    PMID: 34047774
  12. 12

    Panorama of the distal myopathies.

    Savarese M, Sarparanta J, Vihola A, et al.

    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2020; (39(4)):245-265 doi:10.36185/2532-1900-028.

    PMID: 33458580
  13. 13

    Skeletal muscle MRI differentiates SBMA and ALS and correlates with disease severity.

    Klickovic U, Zampedri L, Sinclair CDJ, et al.

    Neurology 2019; (93(9)):e895-e907 doi:10.1212/WNL.0000000000008009.

    PMID: 31391248
  14. 14

    Adding quantitative muscle MRI to the FSHD clinical trial toolbox.

    Mul K, Vincenten SCC, Voermans NC, et al.

    Neurology 2017; (89(20)):2057-2065 doi:10.1212/WNL.0000000000004647.

    PMID: 29030457
  15. 15

    Muscle-MRI and Functional Levels for the Evaluation of Upper Limbs in Duchenne Muscular Dystrophy: A Critical Review of the Literature.

    Cristiano L, Brogna C, Tasca G, et al.

    Medicina (Kaunas, Lithuania) 2022; (58(3)) doi:10.3390/medicina58030440.

    PMID: 35334617
  16. 16

    Juvenile Dermatomyositis: Key Roles of Muscle Magnetic Resonance Imaging and Early Aggressive Treatment.

    Corral-Magaña O, Bauzá-Alonso AF, Escudero-Góngora MM, et al.

    Actas dermo-sifiliograficas 2018; (109(6)):e42-e46 doi:10.1016/j.ad.2017.07.003.

    PMID: 28911766
  17. 17

    Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy.

    Alonso-Jimenez A, Kroon RHMJM, Alejaldre-Monforte A, et al.

    Journal of neurology, neurosurgery, and psychiatry 2019; (90(5)):576-585 doi:10.1136/jnnp-2018-319578.

    PMID: 30530568
  18. 18

    Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study.

    Fionda L, Leonardi L, Tufano L, et al.

    Journal of neurology 2024; (271(9)):5864-5874 doi:10.1007/s00415-024-12544-5.

    PMID: 38972019
  19. 19

    Semi-automated volumetry of MRI serves as a biomarker in neuromuscular patients.

    Müller M, Dohrn MF, Romanzetti S, et al.

    Muscle & nerve 2020; (61(5)):600-607 doi:10.1002/mus.26827.

    PMID: 32022288

This page explains the role of muscle MRIs in Welander distal myopathy for educational purposes only. Always consult your neurologist or care team regarding your specific imaging and diagnostic needs.

Get notified when new evidence is published on Distal myopathy, Welander type.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.